Search results: Sage Journals

Available accessCase reportFirst published August, 2026

A case of transient hepatocellular injury in an HIV monoclonal antibody trial

Ishana Harkoo, Parveen Sobia, Derseree Archary [...]

International Journal of STD & AIDS

Available accessResearch articleFirst published December, 2023

Developing a flowchart to evaluate the use of Closed System Drug-Transfer Devices with monoclonal antibodies: Focus on the clinical trial setting

Ine Simal, Tiene Bauters, Charline Paepens [...]

Journal of Oncology Pharmacy Practice

Available accessResearch articleFirst published December, 2024

Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review

Marco Canevelli, Antonio Ancidoni, Martina Valletta [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published 2023

A phase Ia dose-escalation trial of Ametumumab (a fully human monoclonal antibody against epidermal growth factor receptor) in patients with advanced solid malignancies

Da Li, Hong Pan, Wei Wang [...]

Therapeutic Advances in Medical Oncology

Available accessResearch articleFirst published August, 2025

Dose finding in early-phase human immunodeficiency virus type 1 prevention monoclonal antibody clinical trials

Yunda Huang, Bo Zhang, Lily Zhang [...]

Clinical Trials

Restricted accessResearch articleFirst published February, 1992

Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma

Mansoor N. Saleh, M.B. Khazaeli, Richard H. Wheeler [...]

Human Antibodies

Open accessResearch articleFirst published April, 2023

“Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials

Thanin Asawavichienjinda, Seelwan Sathitratanacheewin, Ronpichai Chokesuwattanaskul

Cephalalgia

Free accessReview articleFirst published August, 2019

Safety and tolerability of calcitonin-gene-related peptide binding monoclonal antibodies for the prevention of episodic migraine – a meta-analysis of randomized controlled trials

Da Xu, Deng Chen, Li-na Zhu [...]

Cephalalgia

Available accessResearch articleFirst published February, 2010

Phase I Trial of Weekly Tigatuzumab,an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)

Andres Forero-Torres, Jatin Shah, Tina Wood [...]

Cancer Biotherapy and Radiopharmaceuticals

Open accessReview articleFirst published 2022

Placebo response with subcutaneous injections in calcitonin gene-related peptide receptor monoclonal antibody migraine preventative trials – A systematic review and meta-analysis

Sasikanth Gorantla, Murali Mohan Reddy Gopireddy, Archana Bhat [...]

Cephalalgia Reports

Available accessCase reportFirst published August, 2026

A case of transient hepatocellular injury in an HIV monoclonal antibody trial

Ishana Harkoo, Parveen Sobia, Derseree Archary [...]

International Journal of STD & AIDS

Available accessResearch articleFirst published December, 2023

Developing a flowchart to evaluate the use of Closed System Drug-Transfer Devices with monoclonal antibodies: Focus on the clinical trial setting

Ine Simal, Tiene Bauters, Charline Paepens [...]

Journal of Oncology Pharmacy Practice

Available accessResearch articleFirst published December, 2024

Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review

Marco Canevelli, Antonio Ancidoni, Martina Valletta [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published 2023

A phase Ia dose-escalation trial of Ametumumab (a fully human monoclonal antibody against epidermal growth factor receptor) in patients with advanced solid malignancies

Da Li, Hong Pan, Wei Wang [...]

Therapeutic Advances in Medical Oncology

Available accessResearch articleFirst published August, 2025

Dose finding in early-phase human immunodeficiency virus type 1 prevention monoclonal antibody clinical trials

Yunda Huang, Bo Zhang, Lily Zhang [...]

Clinical Trials

Restricted accessResearch articleFirst published February, 1992

Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma

Mansoor N. Saleh, M.B. Khazaeli, Richard H. Wheeler [...]

Human Antibodies

Open accessResearch articleFirst published April, 2023

“Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials

Thanin Asawavichienjinda, Seelwan Sathitratanacheewin, Ronpichai Chokesuwattanaskul

Cephalalgia

Free accessReview articleFirst published August, 2019

Safety and tolerability of calcitonin-gene-related peptide binding monoclonal antibodies for the prevention of episodic migraine – a meta-analysis of randomized controlled trials

Da Xu, Deng Chen, Li-na Zhu [...]

Cephalalgia

Available accessResearch articleFirst published February, 2010

Phase I Trial of Weekly Tigatuzumab,an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)

Andres Forero-Torres, Jatin Shah, Tina Wood [...]

Cancer Biotherapy and Radiopharmaceuticals

Open accessReview articleFirst published 2022

Placebo response with subcutaneous injections in calcitonin gene-related peptide receptor monoclonal antibody migraine preventative trials – A systematic review and meta-analysis

Sasikanth Gorantla, Murali Mohan Reddy Gopireddy, Archana Bhat [...]

Cephalalgia Reports